scholarly journals Prebiotics Fructo-, Galacto-, and Mannan-Oligosaccharide Do Not Protect against 5-Fluorouracil–Induced Intestinal Mucositis in Rats

2019 ◽  
Vol 149 (12) ◽  
pp. 2164-2173 ◽  
Author(s):  
Roger Yazbeck ◽  
Ruth J Lindsay ◽  
Mark S Geier ◽  
Ross N Butler ◽  
Gordon S Howarth
Keyword(s):  
Body Weight ◽  
Treatment Group ◽  
Myeloperoxidase Activity ◽  
Intestinal Damage ◽  
Small Intestinal Mucosa ◽  
Villus Height ◽  
Mannan Oligosaccharide ◽  
Treatment Groups ◽  
Small Intestinal ◽  
All Treatment

ABSTRACT Background Prebiotics selectively stimulate the growth of beneficial bacteria within the gastrointestinal tract, and have been investigated in human and animal studies for their capacity to improve intestinal health. Objective We investigated the prebiotics fructo-oligosaccharide (FOS), galacto-oligosaccharide (GOS), and mannan-oligosaccharide (MOS) for their potential to alleviate intestinal damage in rats. Methods Female Dark Agouti rats (6–8 wk old, 110–150 g) were allocated to 1 of the following treatment groups (n = 8/group): saline/water, saline/FOS, saline/GOS, saline/MOS, 5-fluorouracil (5FU)/water, 5FU/FOS, 5FU/GOS, and 5FU/MOS. Rats were pretreated with either 5% GOS, MOS, or FOS or vehicle (water) from day −12 to day 0. On day 0, rats received a single intraperitoneal injection of saline or 5FU. Metabolic data were recorded daily and all rats were killed on day 3. Histopathology was quantified in hematoxylin and eosin–stained sections. Intestinal sucrase and myeloperoxidase activity were quantified by biochemical assay. Fecal SCFAs—acetic, propionic, and butyric acid—were also measured. Statistical analysis was by repeated-measures, 2-factor ANOVA or Kruskal–Wallis and Mann–Whitney U test; P < 0.05 was considered statistically significant. Results Body weight was significantly decreased in all treatment groups after 5FU injection, with no change in body weight observed in any prebiotic treatment group. Total food intake was lower by ≥7% in the GOS treatment group pre-5FU than in all other groups (P < 0.05). Ileal villus height was 18% higher in GOS-treated rats pre-5FU than in respective water controls (P < 0.05). Jejunal and ileal villus height and crypt depth were significantly decreased in all treatment groups after 5FU injection, with no prebiotic effect observed. SCFAs were differentially increased in prebiotic treatment groups compared with water-only controls (P < 0.05). Conclusions FOS, GOS, and MOS have differential effects in modifying small intestinal pathology and SCFA profiles in rats with healthy and damaged small intestinal mucosa.

scholarly journals Toxicity of Chlorine Dioxide in Drinking Water

1984 ◽  
Vol 3 (4) ◽  
pp. 277-284 ◽  
Author(s):  
M. S. Abdel-Rahman ◽  
D. Couri ◽  
R. J. Bull
Keyword(s):  
Drinking Water ◽  
Body Weight ◽  
Red Blood Cells ◽  
Chlorine Dioxide ◽  
Blood Cells ◽  
Osmotic Fragility ◽  
Water Supplies ◽  
Treatment Groups ◽  
Small Intestinal ◽  
All Treatment

Chlorine dioxide (CIO2) is currently being considered as an alternate to chlorine as a disinfectant for public water supplies. Studies were conducted to determine the toxicity of CIO2 (0, 1, 10, 100, 1000 mg/L) and its metabolites, CIO-2 and CIO-3 (10, 100 mg/L) in drinking water in rats. After 9 months treatment the osmotic fragility of the red blood cells was decreased in all treatment groups, while a decreased blood glutathione was only observed in the metabolite groups. At 2, 4, and 6 months no significant hematologic changes were noted in treated rats compared to control. However, after 9 months RBC counts, hematocrit, and hemoglobin were decreased in all treatment groups. CIO2, CIO-2, and CIO-3 administered chronically in drinking water for 3 months inhibited the incorporation of 3H-thymidine into nuclei of rat testes. This inhibition was observed in the liver of CIO-2 groups and in the kidney of 100 mg/L CIO2 treatment. The incorporation in small intestinal nuclei was increased in both 10 and 100 mg/L CIO2 and in 10 mg/L CIO-2. The treatment with CI compounds decreased rat body weight in all groups after 10 and 11 months treatment.

Evaluation of unconventional poultry feed in broilers

2019 ◽  
Vol 17 (1) ◽  
Keyword(s):  
Body Weight ◽  
Treatment Group ◽  
Blood Meal ◽  
Feed Consumption ◽  
Trial Period ◽  
Feed Ingredients ◽  
Treatment Groups ◽  
Broiler Production ◽  
Group I ◽  
Unconventional Feed

Background: Commercial broiler is a rapidly growing sector in Bangladesh. The broilers are supplied with the balanced ration prepared from a number of ingredients which are not available uniformly throughout the years. On the other hands, manufactured feeds are costly and inconvenient for the rural farmers. This study is undertaken to use unconventional feed ingredients aiming to decrease the broiler production cost. Method: A total of ninety-nine day- old broiler chicks (Hubbard) of either sex were used in this study in 3 treatment groups to assess processed unconventional feed item (shoti, blood meal, poultry dropping and molasses) on growth and profitability upon rearing for 60 days. Broilers were reared in dip litter system and were fed ad libitum on conventional and unconventional diet dividing into 3 treatment diets namely, treatment diet 1 (T1: Conventional as control), treatment diet 2 (T2: unconventional with blood meal and shoti), and treatment diet 3 (T3: unconventional with blood meal, shoti, poultry droppings and molasses) throughout the trial period. Treatment group 1 (T1) was used as control. Results: Broilers fed on control diet (conventional feed) achieved higher (P<0.01) body weight, while the broilers offered diets with the highest amount of unconventional feed had the lowest body weight. Increased (P<0.01) feed intake was observed during 21days and 49 days of age when broilers fed diets with the supplementation, but no significant differences were found among the groups in terms of feed consumption during 33 day of age. FCR differed significantly (P<.01) throughout the trial period with the broilers fed diets without supplementation of unconventional feed item had the superior FCR than the others. Mortality rate was 6.06%,9.09%, and 9.09% in treatment group I, treatment group II, and treatment group III respectively while live weights, feed conversion and feed consumption was unaffected by all the dietary groups with/without incorporation of unconventional feed item up to day 60 days of age. Statistically significant (P<0.01) decreased live weight was observed among the treatment groups in 60-day-old birds. Productivity and cost-benefit analysis were performed. Conclusion: Use of unconventional feed ingredients in broiler production greatly reduces the feed cost with little hampering the growth rate and hence, it is profitable for the farmers.

scholarly journals Dietary sophorolipid accelerates growth by modulation of gut microbiota population and intestinal environments in broiler chickens

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Min-Jin Kwak ◽  
Min-Young Park ◽  
Yong-Soon Choi ◽  
Junghwan Cho ◽  
Duleepa Pathiraja ◽  
...  
Keyword(s):  
Body Weight ◽  
Barrier Function ◽  
Broiler Chickens ◽  
Pathogenic Bacteria ◽  
Inflammatory Cytokine ◽  
Intestinal Inflammation ◽  
Defense System ◽  
Villus Height ◽  
Treatment Groups ◽  
Gut Barrier Function

Abstract Background Gut is a crucial organ for the host’s defense system due to its filtering action of the intestinal membrane from hazardous foreign substances. One strategy to strengthen the gut epithelial barrier function is to upregulate beneficial microflora populations and their metabolites. Sophorolipid (SPL), which is a glycolipid bio-surfactant, could increase beneficial microflora and decrease pathogenic bacteria in the gastrointestinal tract. Therefore, herein, we conducted an experiment with broiler chickens to investigate the fortifying effects of SPL on the host’s gut defense system by modulating the microbiota population. Methods A total of 540 1-day-old chicks (Ross 308) were used, and they were immediately allotted into three treatment groups (6 replications with 30 chicks/pen) according to their initial body weight. The dietary treatments consisted of CON (basal diet), BAM (10 mg/kg bambermycin), and SPL (10 mg/kg SPL). During the experiment, birds freely accessed feed and water, and body weight and feed intake were measured at the end of each phase. On d 35, birds (one bird/pen) were sacrificed to collect jejunum and cecum samples. Results Dietary SPL and BAM supplementation significantly accelerated birds’ growth and also significantly improved feed efficiency compared to CON. Intestinal microbial community was significantly separated by dietary SPL supplementation from that of CON, and dietary SPL supplementation significantly increased Lactobacillus spp. and Akkermansia muciniphila. Moreover, birds fed with dietary SPL also showed the highest concentration of cecal butyrate among all treatment groups. Gut morphological analysis showed that dietary SPL significantly increased villus height, ratio of villus height to crypt depth, goblet cell numbers, and the gene expression levels of claudin-1 and mucin 2. Additionally, dietary SPL significantly decreased the mRNA expression level of pro-inflammatory cytokine, interleukin-6, and increased that of anti-inflammatory cytokine, interleukin-10, compared to other treatments. Conclusions Dietary SPL increases the beneficial bacterial population and butyrate concentration, which leads to a strengthened gut barrier function. In addition, the intestinal inflammation was also downregulated by dietary SPL supplementation.

scholarly journals Biochemical, Histopathological and Mutagenic Changes Following the Co-administration of Antihelminthic and Antimalarial Drugs in Wistar Rats

2019 ◽  
pp. 1-12
Author(s):  
A. A. Obiajunwa ◽  
E. T. Idowu ◽  
O. A. Otubanjo
Keyword(s):  
Body Weight ◽  
Treatment Group ◽  
Fatty Infiltration ◽  
Portal Tract ◽  
Renal Tissue ◽  
Albino Rats ◽  
Male Adult ◽  
Treatment Groups ◽  
Combination Treatments ◽  
Therapeutic Doses

Aim: To determine the effects of antimalaria and antheminthic drugs combination in the incidence of histopathological alteration and biochemical modulations in liver and kidney of albino rats. Place and Duration of Study: The study was undertaken at the Zoology Department University of Lagos Akoka Lagos Nigeria. Methodology: A total of twenty (25) Male adult albino rats of 13-15 weeks old were divided into 5 groups of 5 rats each and daily oral administration of human therapeutic doses of praziquantel (PZQ 50 mg/kg body weight) separate and in combination with ivermectin (IVM 0.4 mg/kg body weight), albendazole (ALB 15 mg/kg body weight) and Artemether-lumefanthrine (ACT 140 mg/kg body weight) was administered with the  group which serve as the control receiving 1ml distilled water. Toxic effects due to these treatments were investigated using histopathological, biochemical and mutagenic indices at day 8th and 15th of the study. Results: Biochemical assessment revealed significant reduction in AST, ALT, ALP and potassium in the treatment group compared to the control. Increase in the level calcium, Albumin and bicarbonate were also observed in treatment groups. Histopathological assessment of the liver showed a general incidence of focal inflammation along the portal tract area, but did not show any differential severity across treatment groups except for single PZQ treatment group which were characterized by fatty infiltration. A general occurrence of mesangial damage and glomerula injury was observed in kidney tissues. Renal lesions were more severe in single PZQ + IVM treatment groups while mild lesions characterized renal tissue from PZQ+ACT treatment groups. Mutagenic effects as indicated by the high incidence of sperm head abnormalities was recorded across combination treatments especially in PZQ+ IVR and PZQ+ ACT groups. Conclusion: Findings suggest that combination therapies are synergistic and could result in nephrotoxicity, antidiuretic effects, dehydration and mutagenicity at human therapeutic doses.

scholarly journals Glucocorticoid Receptor Agonists to Improve the Productivity and Health of Early-Weaned Pigs: What Is the Best Method of Delivery?

Animals ◽  
2020 ◽  
Vol 10 (7) ◽  
pp. 1124
Author(s):  
Hailey Wooten ◽  
Hwanhee Kim ◽  
Amanda R. Rakhshandeh ◽  
Anoosh Rakhshandeh
Keyword(s):  
Body Weight ◽  
Glucocorticoid Receptor ◽  
Low Dose ◽  
Average Daily Gain ◽  
Feed Ratio ◽  
High Dose ◽  
Suitable Alternative ◽  
Treatment Groups ◽  
Daily Gain ◽  
All Treatment

The purpose of the current study was to determine the best method of delivery for glucocorticoid receptor agonist (GRA) treatment. A total of 167 Pig Improvement Company (PIC) piglets (body weight (BW) 7.35 ± 1.24 kg) were weaned at 25.0 ± 0.81 days of age and randomly assigned to 14 treatment groups based on a 2 × 7 factorial arrangement with sex (gilts vs. barrows), in-feed antibiotic (ANT; 110 mg/kg in-feed tylosin), repeated intramuscular (I.M.) injection of GRA (two injections, 0.2 mg/kg BW dexamethasone (DEX)), low dose in-feed GRA (LF, 2.5 mg/kg diet DEX ), high dose in-feed GRA (HF, 5 mg/kg diet DEX), low dose in-water GRA (LW, 0.8 mg/L DEX ), high dose in-water GRA (HW, 1.6 mg/L DEX ), and no treatment control (CON) as the main factors. Body weight and feed intake were measured daily from days 0 to 7 and weekly from days 7 to 28 post-weaning. The interaction effect for average daily gain (ADG) was significant with gilts performing better in the I.M., ANT, and LF groups (p = 0.05). All treatment groups, with the exception of the HW group, had a higher ADG than the CON group. Gilts in the I.M., LF, and HF groups had the highest ADG compared to other treatment groups (p ≤ 0.05). Sex and the interaction between sex and treatments had no effect on the gain-to-feed ratio (G:F; p ≥ 0.21). All treatment groups had a higher G:F than the CON group (p ≥ 0.04). These results suggest that the low-dose, in-feed GRA treatment is the best GRA delivery method and is a suitable alternative to in-feed sub-therapeutic antibiotics.

scholarly journals Morphology of small intestinal mucosa and intestinal weight change with metabolic type of cattle

2008 ◽  
Vol 53 (No. 10) ◽  
pp. 525-532 ◽  
Author(s):  
R. Zitnan ◽  
J. Voigt ◽  
S. Kuhla ◽  
J. Wegner ◽  
A. Chudy ◽  
...  
Keyword(s):  
Body Weight ◽  
Small Intestine ◽  
Intestinal Mucosa ◽  
High Energy ◽  
Proximal Jejunum ◽  
Small Intestinal Mucosa ◽  
Apparent Digestibility ◽  
Cattle Breeds ◽  
Metabolic Type ◽  
Small Intestinal

The objective of this study was to investigate rumen fermentation, apparent digestibility of nutrients, and morphology of ruminal und intestinal mucosa in two cattle breeds of different metabolic type. From each breed six purebred German Holstein (H) bulls representing the secretion type and six Charolais (CH) bulls representing the accretion type were raised and fattened under identical conditions with <I>semi ad libitum</I> feeding of a high energy diet. The animals were used for a digestion trial started at nine months of age and animals were slaughtered at 18 months of age. Body weight (668 vs. 764 kg, <I>P</I> = 0.011), body weight gain (1 223 vs. 1 385 g/day, <I>P</I> = 0.043), and body protein gain (93 vs. 128 g/day, <I>P</I> = 0.001) were lower in H compared to CH bulls. Protein expense per kg protein accretion was higher in H bulls (13.8 vs. 10.2, <I>P</I> = 0.001). No significant differences were found in concentration and pattern of ruminal short chain fatty acid and in apparent digestibility of organic matter, crude fibre, and N-free extracts. There were no significant differencs in all morphometric traits of rumen mucosa between both cattle breeds. Compared to H, the villi of CH bulls were higher in duodenum (586 vs. 495 &mu;m, <I>P</I> = 0.001) and proximal jejunum (598 vs. 518&mu;m, <I>P</I> < 0.001), the crypt were deeper in duodenum (295 vs. 358, <I>P</I>< 0.001) and proximal jejunum (292 vs. 344 &mu;m, <I>P</I> = 0.020). In contrast, the villi in ileum were higher in H (522 vs. 471 &mu;m, <I>P</I> = 0.006). The weight of total small intestine, as percentage of total body weight, was 1.1 in H and 0.8 in CH (<I>P</I> = 0.002). The utilization of food crude protein was positively related to the duodenal (<I>P</I> = 0.001) and proximal jejunal villus height (<I>P</I> = 0.003) and to the duodenal crypt depth (<I>P</I> < 0.001) and negatively related to weight of small intestine (<I>P</I> = 0.004). It is concluded, that the higher growth potential and feed efficiency in CH bulls compared to H bulls is not caused by differences in digestion processes, but in size of small intestine, and morphology of small intestinal mucosa. Obviously the duodenum and proximal jejunum of CH bulls adapt to increase the absorptive surface due to the increase in nutrient demand.

scholarly journals Reproductive Toxicities Caused by Swainsonine from Locoweed in Mice

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Chenchen Wu ◽  
Ke Feng ◽  
Dezhang Lu ◽  
Dujian Yan ◽  
Tiesuo Han ◽  
...  
Keyword(s):  
Body Weight ◽  
Treatment Group ◽  
Intraperitoneal Injection ◽  
First Generation ◽  
Lower Body ◽  
Estrous Cycles ◽  
Treatment Groups ◽  
Three Generations ◽  
Body Weights ◽  
Liver And Kidney

Swainsonine is the primary toxin in locoweeds. It causes intention tremors, reproductive dysfunction, emaciation, and death. The objective of the present study was to evaluate the potential reproductive and developmental toxicities caused by swainsonine in mice. The treatment groups consisting of three generations of mice were given a range of concentrations of swainsonine by intraperitoneal injection (2.50 mg/kg body weight (BW), 1.20 mg/kg BW, 0.60 mg/kg BW, and 0 mg/kg BW). The 0 mg/kg BW group exhibited significantly fewer estrous cycles and an increased number of estrous ones compared to the 2.50 mg/kg BW, 1.20 mg/kg BW, and 0.60 mg/kg BW groups (P<0.05). All three generations of mice treated with swainsonine had significantly higher spleen, liver, and kidney indices and significantly lower body weights compared to the 0 mg/kg BW group (P<0.05). For the first and second generations of treatment group, the copulation indices and the numbers of live pups on postnatal days (PND) 0, 4, and 15 were significantly decreased compared to those of the 0 mg/kg BW group (P<0.05). The fertility and gestation indices of the treatment group of the first generation were significantly increased compared to the 2.50 mg/kg BW, 1.20 mg/kg BW, and 0.60 mg/kg BW groups of the second generation (P<0.05). Cumulatively, these results indicate that swainsonine may cause reproductive and developmental toxicities in mice in both parents and offspring.

scholarly journals The anticancer activity of ethanol extract of Chromolaena odorata leaves in 7,12-Dimethylbenz[a]anthracene in (DMBA) induced breast cancer Wistar rats (Rattus novergicus)

Pharmacia ◽  
2021 ◽  
Vol 68 (2) ◽  
pp. 493-499
Author(s):  
Hanifah Yusuf ◽  
Reno Keumalazia Kamarlis ◽  
Yusni Yusni ◽  
Marhami Fahriani
Keyword(s):  
Breast Cancer ◽  
Body Weight ◽  
Treatment Group ◽  
Anticancer Activity ◽  
Cancer Control ◽  
Ethanol Extract ◽  
Breast Cancer Chemotherapy ◽  
Treatment Groups ◽  
Post Hoc ◽  
Dose Dependent

Background: Breast cancer chemotherapy with standard drugs such as doxorubicin will induce cardiotoxicity. Therefore, this study aims to evaluate the anticancer activity of C. odorata leaves extract in DMBA induced breast cancer on rats. Methods: Seven groups of Rattus novergicus were used: Four treatment groups of C. odorata extract (500, 1000, 2000, and 4000 mg/kg BW), normal control, breast cancer control, and doxorubicin treatment group. The number, volume, and weight of the nodule and the rats’ body weight were compared among groups. Data was analyzed using paired t-test or one-way ANOVA with post hoc analysis as appropriate. Results: Significant decline of the number, volume, and weight of cancer nodules was observed in the treatment group (p &lt; 0.001). The weight of the cancer nodule at week 16th was also significantly reduced in GCo2000 compared to Gdoxo (p &lt; 0.0001). A significant increase in body weight was also dose-dependent, especially at week 11th (p &lt; 0.05 in all comparisons) and week 16th (p &lt; 0.001 in all comparisons). Conclusion: This study suggested that the ethanol extract of C. odorata leaves has anticancer and antiproliferative activity.

scholarly journals Response and Economic Efficiency of Broiler Chickens fed graded levels of Baker's Yeast (Saccharomyces cerevisiae) supplement

2021 ◽  
Vol 43 (2) ◽  
pp. 304-313
Author(s):  
W. Buba ◽  
T. S. Olugbemi ◽  
J. J Omage ◽  
S. Duru ◽  
A. O Iyiola-Tunji
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Body Weight ◽  
Weight Gain ◽  
Treatment Group ◽  
Economic Efficiency ◽  
Broiler Chickens ◽  
Baker’S Yeast ◽  
Baker's Yeast ◽  
Yeast Saccharomyces Cerevisiae ◽  
Treatment Groups

Two hundred and fifty-five day-old Ross White strain broiler chicks were used to evaluate the Response and economic efficiency of broiler chickens fed graded levels of baker's yeast (saccharomyces cerevisiae) supplement during the harmattan season in the northern guinea savannah zone of Nigeria. There were five treatment groups for both starter and finisher phases. The experiment lasted for eight weeks. Each treatment group had three replicates with 17 birds per replicate and fifty-five birds per group in a completely randomized design (CRD). Treatments 1, 2, 3, 4 and 5 contained 0.0, 0.5, 1.0, 1.5 and 2.0% SC respectively. Results of the starter phase showed significant (P<0.05) differences in terms of final weight gain and feed conversion ratio (FCR). Treatment groups fed the control diet (0.0%), 0.5% and 1% SC had the best final body weight and body weight gain during the starter phase. The FCR was significantly (P<0.05) higher in the treatment group fed 0.5% SC during the starter phase. Mortality was higher (11.76%) in the control group compared to other treatment groups in the starter phase. During the finisher phase, treatment group fed 1.0% SC had significantly (P<0.05) higher final body weight, body weight gain and FCR. Apparent digestibility of crude protein, crude fibre, ether extract, ash, dry matter and nitrogen free extract were better in treatment groups containing SC. The economic efficiency results of this study indicated that the birds fed 1.0% SC were more profitable compared to those fed the control diet. The net profit of the treatment group fed 1.0% SC was N 650.01 compared to the control (N554.35). This study concluded that the optimum inclusion level of Baker's yeast (Saccharomyces cerevisiae) in the diet of broilers starter was 0.5% and 1.0% for finisher diet for improved performance in terms of weight gain and feed conversion ratio (FCR). It is suggested that broiler chicken farmers should be encouraged to include Baker's yeast in the diet of broiler chickens for improved weight productivity and better feed utilization.

Use of meloxicam, buprenorphine, and Maxilene® to assess a multimodal approach for piglet pain management, part 1: surgical castration

2019 ◽  
Vol 28 (4) ◽  
pp. 487-498 ◽  
Author(s):  
AV Viscardi ◽  
PV Turner
Keyword(s):  
Treatment Group ◽  
Boar Taint ◽  
Multimodal Approach ◽  
Routine Procedure ◽  
Treatment Groups ◽  
Time Points ◽  
Post Procedure ◽  
Opioid Administration ◽  
Pig Farms ◽  
All Treatment

Surgical castration of piglets is a routine procedure on commercial pig farms, to prevent boar taint and reduce aggression. This procedure is known to cause pain, yet piglets are often not provided appropriate analgesia for relief. The objective of this study was to assess a multimodal approach to managing post-castration pain in piglets, using 0.4 mg kg–1 meloxicam (MEL), 0.04 mg kg–1 buprenorphine (BUP), and Maxilene® (MAX). Efficacy was evaluated using behavioural indicators, vocalisation, and facial grimace analysis. Male piglets were randomly assigned to one of ten possible treatments (n = 15 piglets per treatment group): MEL + BUP + MAX (castrated or uncastrated); MEL + BUP (castrated or uncastrated); BUP + MAX (castrated or uncastrated); MEL + MAX (castrated or uncastrated); saline (castrated control); or sham (uncastrated control). Castrated piglets in the MEL + BUP + MAX, MEL + BUP, and BUP + MAX treatment groups displayed significantly fewer pain behaviours than piglets administered saline. MEL + MAX was insufficient in reducing surgical castration pain behaviours. At 24 h post-procedure, saline and MEL + MAX-castrated piglets displayed significantly more pain behaviours than all other treatment groups and time-points. Facial grimace analysis indicated that MEL + MAX-castrated piglets had significantly higher grimace scores than MEL + BUP (castrated and uncastrated) and BUP + MAX-uncastrated. There were no significant differences in emitted vocalisations between the analgesia-treated and saline-castrated piglets. All treatment groups with buprenorphine were effective in alleviating castration-associated pain behaviours, suggesting that opioid administration is beneficial for managing piglet castration pain.

Sign in / Sign up

Export Citation Format

Share Document